Assessing the Effect of Selective Serotonin Reuptake Inhibitors in the Prevention of Post-Acute Sequelae of COVID-19

IMPORTANCE: Post-acute sequelae of COVID-19 (PASC) produce significant morbidity, prompting evaluation of interventions that might lower risk. Selective serotonin reuptake inhibitors (SSRIs) potentially could modulate risk of PASC via their central, hypothesized immunomodulatory, and/or antiplatelet...

Descripción completa

Detalles Bibliográficos
Autores principales: Sidky, Hythem, Sahner, David K., Girvin, Andrew T., Hotaling, Nathan, Michael, Sam G., Gersing, Ken
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9665345/
https://www.ncbi.nlm.nih.gov/pubmed/36380766
http://dx.doi.org/10.1101/2022.11.09.22282142

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9665345/
https://www.ncbi.nlm.nih.gov/pubmed/36380766
http://dx.doi.org/10.1101/2022.11.09.22282142

Ejemplares similares